Publicação

Neuthrophil activation markers in chronic renal failure patients under haemodialysis and recombinant human erythropoietin

Detalhes bibliográficos
Autores principais:	Costa, Elísio
Outros Autores:	Rocha, Susana; Rocha-Pereira, Petronila; Castro, Elisabeth; Miranda, Vasco; Faria, Maria Sameiro; Loureiro, António; Quintanilha, Alexandre; Belo, Luís; Santos-Silva, Alice
Assunto:	rhEPO Resistance
Ano:	2007
País:	Portugal
Tipo de documento:	comunicação em conferência
Tipo de acesso:	acesso aberto
Instituição associada:	Instituto Politécnico de Bragança
Idioma:	inglês
Origem:	Biblioteca Digital do IPB

Registos relacionados

Fibrinolytic in chronic renal failure patients under haemodialysis and its retionship to recombinant human erythrpoietin resistance
por: Costa, Elísio
Publicado em: (2007)

Inflammation, T-Cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy
por: Costa, Elísio
Publicado em: (2008)

Band 3 as a marker of erythrocyte changes in chronic renal failure
por: Costa, Elísio
Publicado em: (2007)

T-cell phenotype and inflammation in chronic kidney disease patients under haemodialysis and its relationship to resistance to rhEPO therapy
por: Faria, Maria Sameiro
Publicado em: (2008)

IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy
por: Costa, Elísio
Publicado em: (2008)

Neutrophil activation and resistance to recombinant human erythropoietin therapy in Hemodialysis Patients
por: Costa, Elísio
Publicado em: (2008)

Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure
por: Pereira, Rui
Publicado em: (2010)

Recombinant human erythropoietin therapy has beneffical cardio-renal effects on moderate stages of chronic renal failure in the rat
por: Garrido, P.
Publicado em: (2009)

Haemorheological changes during recombinante human erythropoietin therapy in a rat model of renal failure induced by partial nephrectomy
por: Costa, Elísio
Publicado em: (2008)

Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure
por: Teixeira, Ana Margarida
Publicado em: (2010)

Resistance to recombinant human erythropoietin therapy in haemodialysis patients: Focus on inflammatory cytokines, leukocyte activation, iron status and erythrocyte damage
por: Costa, Elísio
Publicado em: (2009)

Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping
por: Piloto, Nuno
Publicado em: (2009)

Erythropoietin doping as cause of sudden death in athletes: an experimental study
por: Piloto, N.
Publicado em: (2010)

Hemorheological and cardiovascular effects of erythropoietin in a rat model of sports doping
por: Piloto, N.
Publicado em: (2010)

Band 3 profile as a marker of erythrocyte changes in chronic kidney disease patients
por: Costa, Elísio
Publicado em: (2008)

Changes in red blood cells membrane protein composition during hemodialysis procedure
por: Costa, Elísio
Publicado em: (2008)

Resistance to recombinant human erythropoietin therapy in haemodialysis patients
por: Costa, Elísio
Publicado em: (2009)

Recombinant human erythropoietin treatment in a rat model of nephrectomy
por: Ribeiro, Sandra
Publicado em: (2015)

Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia
Publicado em: (2016)

Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.
por: Ribeiro, Sandra
Publicado em: (2016)

Impaired renal endothelial nitric oxide synthase and reticulocyte production as modulators of hypertension induced by recombinant human erythropoietin in the rat
por: Ribeiro, Sandra
Publicado em: (2016)

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients
por: Costa, Elísio
Publicado em: (2009)

DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis
por: Costa, Elísio
Publicado em: (2008)

Altered erythrocyte membrane band 3 profile in chronic renal failure patients under haemodialysis
por: Costa, Elísio
Publicado em: (2007)

Translational control of the human erythropoietin via an upstream open reading frame in cardiac tissue
por: Onofre, Claudia
Publicado em: (2014)

Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat
por: Teixeira, M.
Publicado em: (2012)

Fibrinolytic activity and vascular access inchronic renal failure patients under haemodialysis
por: Costa, Elísio
Publicado em: (2007)

Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis.
por: Oliveira, C
Publicado em: (1992)

Effect of recombinant human erythropoietin in a rat model of moderate chronic renal failure – focus on inflammation, oxidative Stress and function/renoprotection
por: Garrido, P.
Publicado em: (2010)

Erythropoietin in animal models of inflammation
por: Silva, Inês
Publicado em: (2021)

Translation of the human erythropoietin transcript is regulated by an upstream open reading frame in response to hypoxia
por: Barbosa, Cristina
Publicado em: (2014)

European position paper on rhinosinusitis and nasal polyps (EPOS) 2012: Clinical update
por: Santos, Natacha
Publicado em: (2013)

Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B
por: Moreira, Luciana V.
Publicado em: (2015)

Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience.
por: de Sousa, F T
Publicado em: (1990)

Higher fibrinolytic and inflammatory markers are associated with central venous catheters use in chronic kidney disease patients under haemodialysis
por: Costa, Elísio
Publicado em: (2008)

Potential anti-inflammatory effect of erythropoietin in non-clinical studies in vivo: a systematic review
por: Silva, Inês
Publicado em: (2021)

Efficacy and safety of the carbamylated erythropoietin in an animal model of chronic TNBS-induced colitis
por: Alípio, Carolina Rodrigues
Publicado em: (2022)

Evolution of GnRH ligands and receptors in gnathostomata
por: Guilgur, Leonardo G.
Publicado em: (2006)

Competências e valor da função RH: a perceção dos colaboradores
por: Santos, Maria Teresa Rodrigues Ferreira
Publicado em: (2021)

Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia
por: Ribeiro, Sandra
Publicado em: (2016)